Abstract:Naturally occurring protein switches have been repurposed for developing novel biosensors and reporters for cellular and clinical applications1, but the number of such switches is limited, and engineering them is often challenging as each is different. Here, we show that a very general class of protein-based biosensors can be created by inverting the flow of information through de novo designed protein switches in which binding of a peptide key triggers biological outputs of interest2. The designed sensors are modular molecular devices with a closed dark state and an open luminescent state; binding of the analyte of interest drives switching from the closed to the open state. Because the sensor is based purely on thermodynamic coupling of analyte binding to sensor activation, only one target binding domain is required, which simplifies sensor design and allows direct readout in solution. We demonstrate the modularity of this platform by creating biosensors that, with little optimization, sensitively detect the anti-apoptosis protein Bcl-2, the IgG1 Fc domain, the Her2 receptor, and Botulinum neurotoxin B, as well as biosensors for cardiac Troponin I and an anti-Hepatitis B virus (HBV) antibody that achieve the sub-nanomolar sensitivity necessary to detect clinically relevant concentrations of these molecules. Given the current need for diagnostic tools for tracking COVID-193, we used the approach to design sensors of antibodies against SARS-CoV-2 protein epitopes and of the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein. The latter, which incorporates a de novo designed RBD binder4, has a limit of detection of 15 pM and a signal over background of over 50-fold. The modularity and sensitivity of the platform should enable the rapid construction of sensors for a wide range of analytes and highlights the power of de novo protein design to create multi-state protein systems with new and useful functions.

Engineered proteins with sensing and activating modules for automated reprogramming of cellular functions

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Palladium-Triggered Deprotection Chemistry for Protein Activation in Living Cells

Engineered receptors for soluble cellular communication and disease sensing

Engineered Receptors for Soluble Cell-to-Cell Communication

Engineering Intracellular Protein Sensors in Mammalian Cells

Recombinant biosensors for multiplex and super-resolution imaging of phosphoinositides

A signaling inspired synthetic toolkit for efficient production of tyrosine phosphorylated proteins

De novo design of modular and tunable protein biosensors

Modular design of synthetic receptors for programmed gene regulation in cell therapies

Enzyme Reaction-Assisted Programmable Transcriptional Switches for Bioactive Molecule Detection.

Nanomediator-Effector Cascade Systems for Amplified Protein Kinase Activity Imaging and Phosphorylation-Induced Drug Release In Vivo

Isothermal Kinase-Triggered Supramolecular Assemblies As Drug Sensitizers

Photoaffinity-engineered Protein Scaffold for Systematically Exploring Native Phosphotyrosine Signaling Complexes in Tumor Samples

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

Synthetic GPCRs for programmable sensing and control of cell behaviour

Synthetic G protein-coupled receptors for programmable sensing and control of cell behavior

Bispecific Aptamer Induced Artificial Protein-Pairing: A Strategy for Selective Inhibition of Receptor Function.

A FRET-Based Biosensor for Imaging SYK Activities in Living Cells.

Biosynthesis of Multifunctional Transformable Peptides for Inducing Tumor Cell Apoptosis

Conversion of natural cytokine receptors into orthogonal synthetic biosensors